A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

Autor: Bruna Côrtes Rodrigues, Marina Freitas Ferreira, Daniel Holanda Barroso, Jorgeth Oliveira Carneiro da Motta, Carmen Déa Ribeiro de Paula, Cláudia Porto, Sofia Sales Martins, Ciro Martins Gomes, Raimunda Nonata Ribeiro Sampaio

Publikováno v: International Journal for Parasitology: Drugs and Drug Resistance, Vol 14, Iss , Pp 257-263 (2020)

Introduction: The standard therapy for American cutaneous leishmaniasis (ACL) is intravenous meglumine antimoniate (IV-MA). However, treatment interruptions due to adverse events (AEs) and non-adherence are frequent. Consequently, intralesional MA (I

Externí odkaz: https://doaj.org/article/311acb32f0d64e19b7cfd56a04ccbc22

Possible Case of Visceral Form of Introduced New World Leishmaniasis as a Cause of Fever of Unknown Origin in a Young Child

Autor: V.V. Mavrutenkov, N.V. Zhukova

Publikováno v: Zdorovʹe Rebenka, Vol 11, Iss 2.70, Pp 173-178 (2016)

Objective: to present a clinical case of endemic infection — visceral form of New World leishmaniasis as a possible cause of fever of unknown origin in a young child. Mate­rials and Methods. This article contains a description of a possible case o

Externí odkaz: https://doaj.org/article/9b9b76063219474ba9939b3916ccfc74

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

Autor: Sofia Sales Martins, Cláudia Porto, Marina Freitas Ferreira, Jorgeth de Oliveira Carneiro da Motta, Carmen Déa Ribeiro de Paula, Ciro Martins Gomes, Bruna Côrtes Rodrigues, Raimunda Nonata Ribeiro Sampaio, Daniel Holanda Barroso

Publikováno v: International Journal for Parasitology: Drugs and Drug Resistance, Vol 14, Iss, Pp 257-263 (2020)
International Journal for Parasitology: Drugs and Drug Resistance

Introduction The standard therapy for American cutaneous leishmaniasis (ACL) is intravenous meglumine antimoniate (IV-MA). However, treatment interruptions due to adverse events (AEs) and non-adherence are frequent. Consequently, intralesional MA (IL

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ecb5519c9aa56d07c0e6086a054384b
http://www.sciencedirect.com/science/article/pii/S2211320720300440

Molecular and Antigenic Characterization of the Leishmania (Viannia) panamensis Kinetoplastid Membrane Protein-11

Autor: José R Ramírez, Christof Berberich, Andres Jaramillo, Carlos Alonso, Ivan D Vélez

Publikováno v: Memorias do Instituto Oswaldo Cruz, Vol 93, Iss 2, Pp 247-254 (1998)

The kinetoplastid membrane protein 11 (KMP-11) has been recently described in Leishmania (Leishmania) donovani as a major component of the promastigote membrane. Two oligonucleotide primers were synthesized to PCR-amplify the entire coding region of

Externí odkaz: https://doaj.org/article/fe2d8768a7ce4751b833e37be14311ba

Deep chronic cutaneous New World leishmaniasis due to Leishmania guyanensis and trichinellosis in a German returnee from Ecuador

Autor: André Koch, Alena Bitel, Uwe Wollina

Publikováno v: Our Dermatology Online. 10:272-274

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::27b5331f5ae2ed7386d8ae2e239cb4cb
https://doi.org/10.7241/ourd.20193.12